Meningococcal Disease and Meningococcal Meningitis

Authors: Alexandra Danecki, Chris Gray / Editor: Maya K Naravi / Reviewer: Chris Gray / Codes: A5, O3, R2 / Published: 31/01/2022

Recognising the clinical features of invasive meningococcal disease in children.

After completing this session you will be able to:

  • Recognise the clinical features of invasive meningococcal disease in children
  • Provide acute resuscitation to children with suspected invasive meningococcal disease
  • Differentiate between children presenting with meningococcal meningitis and meningococcal septicaemia
  • Explain a rational system for the investigation of children with suspected invasive meningococcal disease
  • Formulate an evidence based emergency department (ED) management plan for children with meningococcal meningitis and/or septicaemia


  1. Scottish Intercollegiate Guidelines Network. Management of invasive meningococcal disease in children and young people. Edinburgh: SIGN 102, 2008.
  2. Health Protection Agency. Enhanced Surveillance of Meningococcal Disease, National Annual Report: July 2002 – June 2003.
  3. GOV.UK Meningococcal disease: guidance on public health management. Guidance 2012. Updated in 2019.
  4. National Institute for Health and Clinical Excellence. Meningitis (bacterial) and meningococcal septicaemia in under 16s: recognition, diagnosis and management. CG[102]. London: NICE, 2010. Updated in 2015.
  5. Hart AC, Thomson APJ. Meningococcal disease and its management in children. BMJ 2006;33;685-690.
  6. Advanced Paediatric Life Support. The Practical Approach. 4th edn. Wiley-Blackwell, 2005.
  7. European Paediatric Life Support Provider Care Manual. 2nd edn. European Resuscitation Council, 2006.
  8. Thompson MJ, Ninis N, Perera R et al. Clinical recognition of meningococcal disease in children and adolescents. Lancet 2006:367:397-403.
  9. Baldwin LN, Henderson A, Thomas P et al. Acute bacterial meningitis in young adults mistaken for substance abuse. BMJ 1993;306(6880):775-776.
  10. Ragunathan L, Ramsey M, Borrow R et al. Clinical features, laboratory findings and management of meningococcal meningitis in England and Wales: report of a 1997 survey. Meningococcal meningitis:1997 survey report. J Infect 2000;40(1):74-79.
  11. Kneen R, Solomon T, Appleton R. The role of lumbar puncture in children with suspected central nervous system infection. BMC Pediatr. 2002 Sep 2;2:8.
  12. Pollard AJ, Britto J, Nadel S, et al. Emergency management of meningococcal disease. Arch Dis Child. 1999 Mar;80(3):290-6.
  13. Riordan FA, Cant AJ. When to do a lumbar puncture. Arch Dis Child. 2002 Sep;87(3):235-7.
  14. Bronska E, Kalmusova J, Dzupova O et al. Dynamics of PCR-based diagnosis in patients with invasive meningococcal disease. Clin Microbiol Infect 2006;12(2):137-141.
  15. Booy R, Habibi P, Nadel S, de Munter C, Britto J, Morrison A, Levin M; Meningococcal Research Group. Reduction in case fatality rate from meningococcal disease associated with improved healthcare delivery. Arch Dis Child. 2001 Nov;85(5):386-90.
  16. Thorburn K, Baines P, Thomson A, Hart CA. Mortality in severe meningococcal disease. Arch Dis Child. 2001 Nov;85(5):382-5.
  17. Brierly J, Carcillo JA, Choong K et al. Clinical practice parameters for hemodynamic support of pediatric and neonatal septic shock: 2007 update from the American College of Critical Care Medicine. Crit Care Med. 2009 Feb;37(2):666-88. Erratum in: Crit Care Med. 2009 Apr;37(4):1536. Skache, Sara [corrected to Kache, Saraswati]; Irazusta, Jose [corrected to Irazuzta, Jose]. PMID: 19325359; PMCID: PMC4447433.
  18. Advanced Life Support Group. Advanced Paediatric Life Support: The Practical Approach (APLS). 5th edn.Wiley-Blackwell
  19. Prasad K, Singhal T, Jain N et al. Third generation cephalosporins versus conventional antibiotics for treating acute bacterial meningitis (Cochrane Review). In: The Cochrane Library, Issue 1, 2006. London: John Wiley & Sons Ltd.
  20. McIntyre PB, Berkey CS, King SM, et al. Dexamethasone as adjunctive therapy in bacterial meningitis. A meta-analysis of randomized clinical trials since 1988. JAMA. 1997 Sep 17;278(11):925-31.
  21. Pollard AJ,Nadel S, Ninis N et al. Emergency management of meningococcal disease: eight years on. Arch Dis Child 2007;92;283-286.
  22. Health Protection Agency. Enhanced Surveillance of Meningococcal Disease, ESMD graphs, Number of deaths due to meningococcal disease by diagnosis: July 1999 – June 2003.
  23. Stiehm ER, Damrosch DS. Factors in the prognosis of meningococcal infection. Review of 63 cases with emphasis on recognition and management of the severely ill patient. J Pediatr. 1966 Mar;68(3):457-67.
  24. GOV.UK Meningococcal, Meningococcal Meningitis and Septicaemia Notifiable. Green Book, Chapter 22. 2016.
  25. GOV.UK Meningococcal disease: guidance, data and analysis. 2014. Updated in 2021.
  26. Nadel S, Levin M, Habibi P. Treatment of meningococcal disease in childhood. In: Cartwright K, ed. Meningococcal Disease. Chichester: John Wiley and Sons, 1995:207-243.
  27. Duarte MC, Amorim MR, Cuevas LE, et al. Risk factors for death from meningococcal infection in Recife, Brazil. J Trop Pediatr. 2005 Aug;51(4):227-31.
  28. Malley R, Huskins WC, Kuppermann N. Multivariable predictive models for adverse outcome of invasive meningococcal disease in children. J Pediatr. 1996 Nov;129(5):702-10.
  29. Smith I, Bjornevik AT, Augland IM et al. Variations in case fatality and fatality risk factors of meningococcal disease in western Norway, 1985-2002. Epidemiol Infect 2006;134(1):103-110.
  30. Ninis N, Phillips C, Bailey L, Pollock JI, et al. The role of healthcare delivery in the outcome of meningococcal disease in children: case-control study of fatal and non-fatal cases. BMJ. 2005 Jun 25;330(7506):1475.
  31. Duc G, Largo RH. Anterior fontanel: size and closure in term and preterm infants. Pediatrics. 1986 Nov;78(5):904-8. PMID: 3763303.
  32. Kissoon N, Orr RA, Carcillo JA. Updated American College of Critical Care Medicine–pediatric advanced life support guidelines for management of pediatric and neonatal septic shock: relevance to the emergency care clinician. Pediatr Emerg Care. 2010 Nov;26(11):867-9.
  33. Ladhani SN, Andrews N, et al. Vaccination of Infants with Meningococcal Group B Vaccine (4CMenB) in England. N Engl J Med 2020; 382:309-317.
  34. National Institute for Health and Clinical Excellence. CIPROFLOXACIN. Indications and dose.
  35. GOV.UK Health Profile for England Chapter 2: major causes of death and how they have changed. 2017.

Leave a Reply